Publications | Lund University Publications

101 – 110 of 273

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+V1001057&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
10
11
12
13
…
28
next »

2013
Mark Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Gouw, Samantha C. ; van den Berg, H. Marijke ; Fischer, Kathelijn ; Auerswald, Guenter ; Carcao, Manuel ; Chalmers, Elizabeth ; Chambost, Herve ; Kurnik, Karin ; Liesner, Ri and Petrini, Pia , et al. (2013) In Blood 121(20). p.4046-4055
- Contribution to journal › Article
Mark 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.
Ljung, Rolf ^LU ; Karim, F A ; Saxena, K ; Suzuki, Toru ^LU ; Arkhammar, P ; Rosholm, A and Giangrande, P (2013) In Journal of Thrombosis and Haemostasis 11(7). p.1260-1268
- Contribution to journal › Article
Mark Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
Ljung, Rolf ^LU ; Auerswald, G ; Benson, G ; Jetter, A ; Jiménez-Yuste, V ; Lambert, T ; Morfini, M ; Remor, E ; Sørensen, B and Salek, S Z (2013) In Haemophilia 19(4). p.481-486
- Contribution to journal › Scientific review
Mark Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Gouw, Samantha C. ; van der Bom, Johanna G. ; Ljung, Rolf ^LU ; Escuriola, Carmen ; Cid, Ana R. ; Claeyssens-Donadel, Segolene ; van Geet, Christel ; Kenet, Gili ; Makipernaa, Anne and Molinari, Angelo Claudio , et al. (2013) In New England Journal of Medicine 368(3). p.231-239
- Contribution to journal › Article
Mark Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
Fischer, Kathelijn ; Steen Carlsson, Katarina ^LU ; Petrini, Pia ; Holmstrom, Margareta ; Ljung, Rolf ^LU ; van den Berg, H. Marijke and Berntorp, Erik ^LU (2013) In Blood 122(7). p.1129-1136
- Contribution to journal › Article
Mark Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
Carcao, Manuel D. ; van den Berg, H. Marijke ; Ljung, Rolf ^LU and Mancuso, Maria Elisa (2013) In Blood 121(19). p.3946-3952
- Contribution to journal › Article
Mark Hemophilia and prophylaxis.
Ljung, Rolf ^LU (2013) In Pediatric Blood & Cancer 60(Suppl. S1). p.23-26
- Contribution to journal › Scientific review
2012
Mark Haemophilia Care in Europe: the ESCHQoL study
Schramm, W. ; Gringeri, A. ; Ljung, Rolf ^LU ; Berger, K. ; Crispin, A. ; Bullinger, M. ; Giangrande, P. L. F. ; Von Mackensen, S. ; Mantovani, L. G. and Nemes, L. , et al. (2012) In Haemophilia 18(5). p.729-737
- Contribution to journal › Article
Mark Beyond patient benefit: clinical development in hemophilia
Auerswald, Guenter ; Salek, Silva Zupancic ; Benson, Gary ; Elezovic, Ivo ; Lambert, Thierry ; Morfini, Massimo ; Pasi, John ; Remor, Eduardo ; Santagostino, Elena and Salaj, Peter , et al. (2012) In Hematology 17(1). p.1-8
- Contribution to journal › Scientific review
Mark Origin of Swedish hemophilia A mutations
Halldén, C. ; Nilsson, D. ; Säll, Torbjörn ^LU ; Lind-Hallden, C. ; Liden, A. C. and Ljung, Rolf ^LU (2012) In Journal of Thrombosis and Haemostasis 10(12). p.2503-2511
- Contribution to journal › Article

« previous
1
…
10
11
12
13
…
28
next »

your query:: Remove department: Paediatric Haematology Research Unit